HHS OIG: West Virginia Failed to Collect $6.1M in Medicaid Drug Rebates

The HHS Office of Inspector General (OIG) has issued a report detailing that West Virginia failed to obtain an estimated $6.1 million in federal rebates from manufacturers for physician-administered drugs dispensed to Medicaid managed-care enrollees. The audit, conducted by the OIG, found that while West Virginia had policies in place to collect the necessary drug utilization data, its internal controls were insufficient to ensure this data was used to invoice manufacturers and collect the owed rebates.

This finding necessitates that West Virginia refund the $6.1 million federal share to the U.S. government. Although West Virginia did not concur with the OIG's recommendations, it has described corrective actions taken and planned. Compliance officers should review their state's Medicaid drug rebate invoicing processes, particularly for physician-administered drugs within managed care, to ensure robust internal controls are in place to prevent similar financial losses and potential future liabilities.